Financial results - R&D MEDCONSULT SRL

Financial Summary - R&D Medconsult Srl
Unique identification code: 16032513
Registration number: J40/177/2004
Nace: 7219
Sales - Ron
173.181
Net Profit - Ron
129.424
Employees
2
Open Account
Company R&D Medconsult Srl with Fiscal Code 16032513 recorded a turnover of 2024 of 173.181, with a net profit of 129.424 and having an average number of employees of 2. The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - R&D Medconsult Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 93.315 110.181 117.433 65.299 121.271 52.387 161.917 177.536 138.389 173.181
Total Income - EUR 104.004 119.969 131.988 67.978 123.032 53.620 165.217 186.544 144.045 189.670
Total Expenses - EUR 24.891 37.899 47.044 32.598 33.898 18.737 39.263 52.309 61.938 55.424
Gross Profit/Loss - EUR 79.113 82.070 84.944 35.379 89.134 34.883 125.954 134.235 82.107 134.246
Net Profit/Loss - EUR 66.001 68.850 82.351 34.709 87.921 34.386 124.384 132.454 80.833 129.424
Employees 0 1 1 1 1 0 2 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 25.8%, from 138.389 euro in the year 2023, to 173.181 euro in 2024. The Net Profit increased by 49.042 euro, from 80.833 euro in 2023, to 129.424 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - R&D Medconsult Srl

Rating financiar

Financial Rating -
R&D MEDCONSULT SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
R&D Medconsult Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
R&D Medconsult Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
R&D Medconsult Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - R&D Medconsult Srl - CUI 16032513

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 2.211 8.795 5.627 2.233 1.678 505 1.417 668 111 808
Current Assets 189.589 82.008 85.027 43.209 93.832 47.351 145.218 143.152 116.644 208.666
Inventories 0 0 0 0 0 0 0 162 0 0
Receivables 0 34.136 9.537 24.762 32.514 9.433 28.367 127.775 11.602 101.137
Cash 27.446 29.104 22.962 18.447 61.318 37.918 116.851 15.215 28.012 21.890
Shareholders Funds 174.079 75.233 88.626 40.869 93.961 40.312 143.374 138.267 116.125 135.186
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 17.720 16.143 2.028 4.572 1.548 7.544 3.506 5.553 1.751 74.565
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 208.666 euro in 2024 which includes Inventories of 0 euro, Receivables of 101.137 euro and cash availability of 21.890 euro.
The company's Equity was valued at 135.186 euro, while total Liabilities amounted to 74.565 euro. Equity increased by 19.710 euro, from 116.125 euro in 2023, to 135.186 in 2024.

Risk Reports Prices

Reviews - R&D Medconsult Srl

Comments - R&D Medconsult Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.